Literature DB >> 11745730

Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.

H H Chow1, N Anavy, A Villalobos.   

Abstract

In our previous research, cocaine applied intranasally in rats diffused or was transported directly from the nasal cavity to the brain. However, the direct nose-brain cocaine transport only contributes to an initial increase in the relative cocaine brain exposure. In this study, we have determined the nose-brain transport of a polar metabolite of cocaine, benzoylecgonine, to help understand factors affecting drug transport via this novel pathway. The nasal cavity of male Sprague-Dawley rats was isolated to prevent drainage of nasally applied dosing solution to non-nasal regions. Benzoylecgonine was then administered, either by intranasal administration or by intravenous (iv) injection. At different times postdose, blood and tissues from different regions of the brain were collected from groups of rats (n = 4 for each collection time) and benzoylecgonine concentrations in these samples were analyzed by high-performance liquid chromatography. Benzoylecgonine concentrations in plasma were at maximal levels immediately after iv dosing and declined as a function of time. Following intranasal administration, benzoylecgonine concentrations in plasma reached maximal levels between 15 and 30 min after dosing and declined as a function of time. To allow comparison of brain benzoylecgonine content after iv and intranasal administration, brain benzoylecgonine contents were normalized by plasma benzoylecgonine concentrations. The ratios of the area under the benzoylecgonine concentration-time curve (AUC) between the olfactory bulb and plasma following intranasal administration were 10-100 times higher than those obtained after iv dosing. The olfactory tract-to-plasma benzoylecgonine AUC ratios after intranasal administration were significantly higher than those after iv dosing up to 120 min following dosing. The brain tissue-to-plasma AUC ratios in cerebellum, brain stem, and cerebral cortex after intranasal administration were significantly higher than the corresponding ratios after iv administration up to 30 min following dosing. We conclude than nasally administered benzoylecgonine was transported directly from the nasal cavity to the brain and that the significant increase in brain levels was sustained for a prolonged period of time. Factors contributing to the observed differences in the nose-brain transport of cocaine and benzoylecgonine are discussed. Copyright 2001 Wiley-Liss, Inc. and the American Pharmaceutical Association

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745730     DOI: 10.1002/jps.1122

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  14 in total

1.  Intranasal delivery--modification of drug metabolism and brain disposition.

Authors:  Yin Cheong Wong; Zhong Zuo
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

2.  Effects of localized hydrophilic mannitol and hydrophobic nelfinavir administration targeted to olfactory epithelium on brain distribution.

Authors:  John Douglas Hoekman; Rodney J Y Ho
Journal:  AAPS PharmSciTech       Date:  2011-04-26       Impact factor: 3.246

3.  Nose-to-brain transport of melatonin from polymer gel suspensions: a microdialysis study in rats.

Authors:  R Jayachandra Babu; Pankaj Patrick Dayal; Kasturi Pawar; Mandip Singh
Journal:  J Drug Target       Date:  2011-03-23       Impact factor: 5.121

4.  Pharmacokinetics of substrate uptake and distribution in murine brain after nasal instillation.

Authors:  Candace L Graff; Rong Zhao; Gary M Pollack
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

5.  Permeation and metabolism of cocaine in the nasal mucosa.

Authors:  Hefei Zhang; Thomas E Prisinzano; Maureen D Donovan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-02-18       Impact factor: 2.441

6.  Direct nose-to-brain transfer of morphine after nasal administration to rats.

Authors:  Ulrika Espefält Westin; Emma Boström; Johan Gråsjö; Margareta Hammarlund-Udenaes; Erik Björk
Journal:  Pharm Res       Date:  2006-02-25       Impact factor: 4.200

7.  P-Glycoprotein attenuates brain uptake of substrates after nasal instillation.

Authors:  Candace L Graff; Gary M Pollack
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

8.  Characterization of focused ultrasound-mediated brainstem delivery of intranasally administered agents.

Authors:  Dezhuang Ye; Jingyi Luan; Hannah Pang; Yaoheng Yang; Arash Nazeri; Joshua B Rubin; Hong Chen
Journal:  J Control Release       Date:  2020-08-29       Impact factor: 9.776

9.  Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20).

Authors:  Gloriane W Schnabolk; Geri L Youngblood; Douglas H Sweet
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-14

10.  CNS Delivery and Anti-Inflammatory Effects of Intranasally Administered Cyclosporine-A in Cationic Nanoformulations.

Authors:  Sunita Yadav; Grishma Pawar; Praveen Kulkarni; Craig Ferris; Mansoor Amiji
Journal:  J Pharmacol Exp Ther       Date:  2018-12-27       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.